M. L. Vegna - Concepedia

Author

M. L. Vegna

Sapienza University of Rome

Also Known As

M L Vegna, M. L. Vegna, M.L. Vegna, MARIA LUCE VEGNA, Maria L. Vegna, Maria Luce Vegna

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Sapienza University of Rome Hôtel-Dieu de Paris Istituto di Ematologia di Bologna Ospedale Policlinico San Martino European Organisation for Research and Treatment of Cancer

About

M. L. Vegna is an author at Sapienza University of Rome specializing in oncology, medicine, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	204
2	Health Sciences	4	4	106
3	Pathology	4	4	143
4	Immunology	2	2	98
5	Marrow Transplantation	1	1	29

M. L. Vegna

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Autologous or Allogeneic Bone Marrow Transplantation Compared with Intensive Chemotherapy in Acute Myelogenous Leukemia R Zittoun, Franco Mandelli, Roel Willemze, New England Journal of Medicine	1995	853
Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Franco Mandelli, Daniela Diverio, Giuseppe Avvisati, PubMed	1997	474
Maintenance Treatment with Recombinant Interferon Alfa-2b in Patients with Multiple Myeloma Responding to Conventional Induction Chemotherapy Franco Mandelli, Giuseppe Avvisati, Sergio Amadori, New England Journal of Medicine	1990	385
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study Luciana Annino, M. L. Vegna, Andrea Camera, Blood	2002	350
Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases Cesare Guglielmi, Maria Paola Martelli, Daniela Diverio, British Journal of Haematology	1998	197
p53 Expression in B-Cell Chronic Lymphocytic Leukemia: A Marker of Disease Progression and Poor Prognosis Iole Cordone, Serena Masi, Francesca Romana Mauro, Blood	1998	177
Multimodality Treatment of Thymoma: A Prospective Study Federico Venuta, Erino Angelo Rendina, Edoardo Pescarmona, The Annals of Thoracic Surgery MultimodalityThyroid HormoneImmunotherapyMultimodality TherapyNuclear Medicine	1997	131
Early haemorrhagic morbidity and mortality during remission induction with or without all‐<i>trans</i> retinoic acid in acute promyelocytic leukaemia Eros Di Bona, Giuseppe Avvisati, Giancarlo Castaman, British Journal of Haematology	2000	130
The influence of HLA‐matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA S. Keating, Théo de Witte, Stefan Suciu, British Journal of Haematology	1998	91
Idarubicin (4‐demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: A pilot study of the Italian cooperative group GIMEMA Giuseppe Avvisati, Franco Mandelli, Maria Concetta Petti, European Journal Of Haematology	1990	79

Page 1